APA
Martín M., Ruiz Simón A., Ruiz Borrego M., Ribelles N., Rodríguez-Lescure Á., Muñoz-Mateu M., González S., Margelí Vila M., Barnadas A., Ramos M., Del Barco Berron S., Jara C., Calvo L., Martínez-Jáñez N., Mendiola Fernández C., Rodríguez C. A., Martínez de Dueñas E., Andrés R., Plazaola A., de la Haba-Rodríguez J., López-Vega J. M., Adrover E., Ballesteros A. I., Santaballa A., Sánchez-Rovira P., Baena-Cañada J. M., Casas M., del Carmen Cámara M., Carrasco E. M. & Lluch A. (20160212). Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Martín Miguel, Ruiz Simón Amparo, Ruiz Borrego Manuel, Ribelles Nuria, Rodríguez-Lescure Álvaro, Muñoz-Mateu Montserrat, González Sonia, Margelí Vila Mireia, Barnadas Agustí, Ramos Manuel, Del Barco Berron Sonia, Jara Carlos, Calvo Lourdes, Martínez-Jáñez Noelia, Mendiola Fernández César, Rodríguez César A, Martínez de Dueñas Eduardo, Andrés Raquel, Plazaola Arrate, de la Haba-Rodríguez Juan, López-Vega Jose Manuel, Adrover Encarna, Ballesteros Ana Isabel, Santaballa Ana, Sánchez-Rovira Pedro, Baena-Cañada José M, Casas Maribel, del Carmen Cámara María, Carrasco Eva Maria and Lluch Ana. 20160212. Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Martín M., Ruiz Simón A., Ruiz Borrego M., Ribelles N., Rodríguez-Lescure Á., Muñoz-Mateu M., González S., Margelí Vila M., Barnadas A., Ramos M., Del Barco Berron S., Jara C., Calvo L., Martínez-Jáñez N., Mendiola Fernández C., Rodríguez C. A., Martínez de Dueñas E., Andrés R., Plazaola A., de la Haba-Rodríguez J., López-Vega J. M., Adrover E., Ballesteros A. I., Santaballa A., Sánchez-Rovira P., Baena-Cañada J. M., Casas M., del Carmen Cámara M., Carrasco E. M. and Lluch A. (20160212). Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Martín Miguel, Ruiz Simón Amparo, Ruiz Borrego Manuel, Ribelles Nuria, Rodríguez-Lescure Álvaro, Muñoz-Mateu Montserrat, González Sonia, Margelí Vila Mireia, Barnadas Agustí, Ramos Manuel, Del Barco Berron Sonia, Jara Carlos, Calvo Lourdes, Martínez-Jáñez Noelia, Mendiola Fernández César, Rodríguez César A, Martínez de Dueñas Eduardo, Andrés Raquel, Plazaola Arrate, de la Haba-Rodríguez Juan, López-Vega Jose Manuel, Adrover Encarna, Ballesteros Ana Isabel, Santaballa Ana, Sánchez-Rovira Pedro, Baena-Cañada José M, Casas Maribel, del Carmen Cámara María, Carrasco Eva Maria and Lluch Ana. Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20160212.